Millennium Management
JUNO

Millennium Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Millennium Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100,000
Closed -$2.22M – 4117
2017
Q1 		$2.22M Buy
+100,000
New +$2.14M ﹤0.01% 1952
2016
Q4 		– Sell
-18,000
Closed -$540K – 3959
2016
Q3 		$540K Buy
+18,000
New +$560K ﹤0.01% 2569

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Millennium Management's JUNO Position: Q1 2018 in Review

Millennium Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 14,587 shares — an estimated $667K sold.

Millennium Management first reported a position in JUNO in Q4 2014 and held it in 9 quarters. The position peaked at $12.8M in Q2 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Millennium Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Millennium Management sold 14,587 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $667K.
  • Millennium Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
  • Millennium Management's Juno Therapeutics, Inc. position peaked at $12.8M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.